Pancreatic cancer: understanding and overcoming chemoresistance (Q37811882)

23 August 2017

Pancreatic cancer: understanding and overcoming chemoresistance (English)

1 reference

23 August 2017

1 reference

5

1 reference

23 August 2017

3

0 references

Fazlul H. Sarkar

series ordinal

7

object named as

Fazlul H Sarkar

1 reference

23 August 2017

4

Sanjeev Banerjee

1 reference

23 August 2017

6

Dejuan Kong

1 reference

23 August 2017

Zhiwei Wang

1

1 reference

23 August 2017

Yiwei Li

series ordinal

2

1 reference

23 August 2017

language of work or name

English

0 references

publication date

23 November 2010

1 reference

Nature Reviews Gastroenterology & Hepatology

23 August 2017

1 reference

23 August 2017

8

1 reference

23 August 2017

27-33

1 reference

23 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2010.188

23 August 2017

0 references

cites work

MicroRNAs as regulators of epithelial-mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Targeting multidrug resistance in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Mechanisms of cancer drug resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Integrins as novel drug targets for overcoming innate drug resistance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Targeting Notch signaling pathway to overcome drug resistance for cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Implication of microRNAs in drug resistance for designing novel cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Epithelial-mesenchymal transitions in development and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Development and characterization of gemcitabine-resistant pancreatic tumor cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Functional analysis of LOXL2 in pancreatic carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

The therapeutic promise of the cancer stem cell concept

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Pancreatic cancer stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Identification of pancreatic cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

The epithelial-mesenchymal transition generates cells with properties of stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Targeting microRNAs in cancer: rationale, strategies and challenges

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Genetic variation in microRNA networks: the implications for cancer research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

miR-146a suppresses invasion of pancreatic cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Complex networks orchestrate epithelial-mesenchymal transitions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Identification of selective inhibitors of cancer stem cells by high-throughput screening

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.188

Dietary polyphenol quercetin targets pancreatic cancer stem cells.

31 March 2020

1 reference

12 December 2020

Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic

1 reference

12 December 2020

Emerging roles of PDGF-D signaling pathway in tumor development and progression

1 reference

12 December 2020

The role of KRAS mutations in resistance to EGFR inhibition in the treatment of cancer.

1 reference

12 December 2020

Side population in the pancreatic cancer cell lines SW1990 and CFPAC-1 is enriched with cancer stem-like cells.

1 reference

12 December 2020

Effect of anti-cancer drugs on the expression of BIC/miR-155 in human pancreatic cancer PANC-1 cells

1 reference

12 December 2020

10.1038/NRGASTRO.2010.188

Identifiers

DOI

1 reference

Dimensions Publication ID

23 August 2017

0 references

1 reference